Leukemia + Lymphoma Research

Clinical trials may not always represent diverse communities. At Lilly, we are trying to change this to give everybody the chance to participate. We want to include people of all races, ages, ethnicities, genders, and body weights who may potentially benefit from taking part in a clinical trial. Genetic or physical differences between people can mean that some might react differently to a medicine or treatment. For these reasons, it is important to represent all people in clinical trials.

The wellbeing of participants is very important to the medical professionals who conduct clinical trials. The main responsibility of the healthcare team who lead clinical trials is to care for participants. The people in this team may have unfamiliar titles like Principal Investigators or Study Coordinators but they are also doctors, nurses and trained researchers. This means that they are trained to look after your safety and health. The FDA as well as other regulatory bodies also have safety guidelines in place to protect people who take part in clinical trials.

For most clinical trials, the study medicine is provided, and visits are conducted at no cost to the participant. However, this is not the case for all trials.

Some clinical trials reimburse people who take part in clinical trials for their time and travel. These reimbursements, if any, tend to vary based upon the phase of the trial and type of visit. Any costs or reimbursements will be fully explained to participants before deciding to join a clinical trial during the informed consent process.

Participants, also known as volunteers, are at the center of clinical trials. Research for new medicines and treatments is not possible without the contribution that these volunteers make by participating in a clinical trial. At Lilly, we are deeply grateful to the volunteers that make clinical trials possible.

Lilly makes clinical trial results available to the public. You can view the results of clinical trials here.